[Medical tocolysis in threatening premature labor: what is safe in therapy?].
Grospietsch
G
G
Frauenklinik und Hebammenlehranstalt am Städtischen Klinikum Braunschweig.
D000284:Administration, Oral; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D001724:Birth Weight / Q000187:drug effects; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy; D006801:Humans; D007231:Infant, Newborn; D007262:Infusions, Intravenous; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D015149:Tocolytic Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D000318:Adrenergic beta-Agonists; D015149:Tocolytic Agents
Medikamentöse Tokolyse bei der drohenden Frühgeburg: Was ist gesichert in der Therapie?